貝瑞基因(000710.SZ)2股東擬減持不超5.58%股份
格隆匯8月23日丨貝瑞基因(000710.SZ)公佈,持有公司股份5160.50萬股(佔公司總股本比例約14.5528%)的股東天津君睿祺股權投資合夥企業(有限合夥)(以下簡稱“天津君睿祺”)計劃在2019年9月16日至2020年3月15日期間以集中競價交易、大宗交易方式減持公司股份不超過1950萬股(佔公司總股本比例約5.4991%)。
持有公司股份111.30萬股(佔公司總股本比例約0.3139%)的股東王冬計劃在2019年9月16日至2019年12月31日期間以集中競價交易方式減持公司股份不超過27.83萬股(佔本公司總股本比例約0.0785%)。
天津君睿祺和王冬將按照以下規定實施上述股份減持計劃:“通過證券交易所集中競價交易方式,任意連續90個自然日內減持股份總數將不超過公司股份總數的1%;通過證券交易所大宗交易方式,任意連續90個自然日內減持股份總數將不超過公司股份總數的2%;董監高在任期內每年轉讓的股份不超過其所持有公司股份總數的25%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.